376 related articles for article (PubMed ID: 38191508)
1. Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways.
Liu D; Che X; Wu G
Biomark Res; 2024 Jan; 12(1):5. PubMed ID: 38191508
[TBL] [Abstract][Full Text] [Related]
2. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.
Zhao Y; Morgan MA; Sun Y
Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumor angiogenesis by targeting the protein neddylation pathway.
Yao WT; Wu JF; Yu GY; Wang R; Wang K; Li LH; Chen P; Jiang YN; Cheng H; Lee HW; Yu J; Qi H; Yu XJ; Wang P; Chu YW; Yang M; Hua ZC; Ying HQ; Hoffman RM; Jeong LS; Jia LJ
Cell Death Dis; 2014 Feb; 5(2):e1059. PubMed ID: 24525735
[TBL] [Abstract][Full Text] [Related]
4. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.
Wang Y; Luo Z; Pan Y; Wang W; Zhou X; Jeong LS; Chu Y; Liu J; Jia L
Cancer Biol Ther; 2015; 16(3):420-9. PubMed ID: 25782162
[TBL] [Abstract][Full Text] [Related]
5. Neddylation-Independent Activities of MLN4924.
Mao H; Sun Y
Adv Exp Med Biol; 2020; 1217():363-372. PubMed ID: 31898238
[TBL] [Abstract][Full Text] [Related]
6. Targeting Protein Neddylation for Cancer Therapy.
Zhou L; Jia L
Adv Exp Med Biol; 2020; 1217():297-315. PubMed ID: 31898235
[TBL] [Abstract][Full Text] [Related]
7. Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication.
Jiang Y; Jia L
Anticancer Agents Med Chem; 2015; 15(9):1127-33. PubMed ID: 25742093
[TBL] [Abstract][Full Text] [Related]
8. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells.
Lan H; Tang Z; Jin H; Sun Y
Sci Rep; 2016 Apr; 6():24218. PubMed ID: 27063292
[TBL] [Abstract][Full Text] [Related]
9. Neddylation in the chronically hypoperfused corpus callosum: MLN4924 reduces blood-brain barrier injury via ERK5/KLF2 signaling.
Yang X; Chang L; Liu Z; Geng X; Wang R; Yin X; Fan W; Zhao BQ
Exp Neurol; 2024 Jan; 371():114587. PubMed ID: 37914067
[TBL] [Abstract][Full Text] [Related]
10. Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus.
Flores-MartÃnez YA; Le-Trilling VTK; Trilling M
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452475
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of neddylation induces mitotic defects and alters MKLP1 accumulation at the midbody during cytokinesis.
Chung D; Salsman J; Dellaire G
Cell Cycle; 2019 May; 18(10):1135-1153. PubMed ID: 31057046
[TBL] [Abstract][Full Text] [Related]
12. Neddylation: a novel modulator of the tumor microenvironment.
Zhou L; Jiang Y; Luo Q; Li L; Jia L
Mol Cancer; 2019 Apr; 18(1):77. PubMed ID: 30943988
[TBL] [Abstract][Full Text] [Related]
13. Protein neddylation and its alterations in human cancers for targeted therapy.
Zhou L; Zhang W; Sun Y; Jia L
Cell Signal; 2018 Apr; 44():92-102. PubMed ID: 29331584
[TBL] [Abstract][Full Text] [Related]
14. Neddylation Facilitates the Antiviral Response in Zebrafish.
Yu G; Liu X; Tang J; Xu C; Ouyang G; Xiao W
Front Immunol; 2019; 10():1432. PubMed ID: 31293590
[TBL] [Abstract][Full Text] [Related]
15. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
Xu B; Deng Y; Bi R; Guo H; Shu C; Shah NK; Chang J; Liu G; Du Y; Wei W; Wang C
Cancer Chemother Pharmacol; 2018 Jun; 81(6):1083-1093. PubMed ID: 29667067
[TBL] [Abstract][Full Text] [Related]
16. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.
Zhou H; Lu J; Yang CY; Sun Y; Wang S
Adv Exp Med Biol; 2020; 1217():349-362. PubMed ID: 31898237
[TBL] [Abstract][Full Text] [Related]
17. MLN4924 is an efficient inhibitor of NEDD8 conjugation in plants.
Hakenjos JP; Richter R; Dohmann EM; Katsiarimpa A; Isono E; Schwechheimer C
Plant Physiol; 2011 Jun; 156(2):527-36. PubMed ID: 21527421
[TBL] [Abstract][Full Text] [Related]
18. Overactivated neddylation pathway as a therapeutic target in lung cancer.
Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L
J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380
[TBL] [Abstract][Full Text] [Related]
19. Neddylation inhibitor, MLN4924 suppresses angiogenesis in huvecs and solid cancers:
Shi CS; Kuo KL; Lin WC; Chen MS; Liu SH; Liao SM; Hsu CH; Chang YW; Chang HC; Huang KH
Am J Cancer Res; 2020; 10(3):953-964. PubMed ID: 32266102
[TBL] [Abstract][Full Text] [Related]
20. Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen.
Qu B; Nebioglu F; Leuthold MM; Ni Y; Mutz P; Beneke J; Erfle H; Vondran FWR; Bartenschlager R; Urban S
JHEP Rep; 2022 Oct; 4(10):100551. PubMed ID: 36124123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
